This latest addition to Implications of Contemporary Clinical Trials provides readers with a broad range of perspectives on a dramatic addition to the cardiologist's therapeutic armamentarium: transcatheter aortic valve replacement (sometimes referred to as transcatheter aortic valve implantation). This new treatment for hemodynamically severe, symptomatic aortic stenosis represents a triumph of modern-day design of a new device and uses creative clinical design methodology. The discussions in this collection of articles cover the development of the transcatheter aortic valve replacement methodology and the pivotal Placement of Aortic Transcatheter Valve Trial (PARTNER) that evaluates its impact; implications from the interventional, surgical, and general cardiology perspectives; and importantly, a critique of the health economic implications of introducing a dramatically effective but expensive new therapy.
